Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients

Clinical trial NCT04512430 · TERMINATED

Trial details

NCT number: NCT04512430
Sponsor: Fundación GECP
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer EGFR Gene Mutation

Start date: 2020-12-02
Primary completion: 2024-07-19
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.